Showing results (261-270 of 339) with videos related to

Sort By:
Pageof 34
Vaccine|July 11, 2016
Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal modelsGermie P J M van den Dobbelsteen, Kellen C Faé, Jan Serroyen, et al.
Vaccine|March 6, 2018
Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised studyClare L Cutland, Terry Nolan, Scott A Halperin, et al.
The Journal of Infection|February 15, 2026
Assessing measles immunity in individuals of childbearing age in Toronto, Ontario, CanadaSelma Osman, Michelle Science, Elizabeth McLachlan, et al.
Pediatrics|September 5, 2006
Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003-2004Dorothy L Moore, Wendy Vaudry, David W Scheifele, et al.
Human Vaccines & Immunotherapeutics|June 10, 2026
Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trialGlenn Hamonic, Supriya Arora, Ravendra Garg, et al.
Vaccine|July 8, 2008
European Sero-Epidemiology Network 2: standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparationsAnna Giammanco, Antony Nardone, Richard Pebody, et al.
Vaccine|December 8, 2010
Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6 and 12-14 months of ageFrancisco Diaz-Mitoma, Scott A Halperin, Bruce Tapiero, et al.
Journal of the Pediatric Infectious Diseases Society|September 4, 2015
Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012-2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical TrialJoanne M Langley, Long Wang, Naresh Aggarwal, et al.
BMC Geriatrics|February 18, 2025
Unveiling the impact: understanding long-term care workers' experiences and their perceptions of resident challenges amidst the COVID-19 pandemicDonna M Halperin, Krista Whitfield, Julie A Bettinger, et al.
Vaccine|March 5, 2026
Adenovirus type 5 vector-based COVID-19 vaccine does not increase the likelihood of HIV infectionGuillermo M Ruiz-Palacios, Pedro Enrique Cahn, Scott A Halperin, et al.
Pageof 34